haloperidol has been researched along with Catatonia in 67 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the relationship between the efficiency of muscarinic receptor antagonists in preventing haloperidol-induced catatonia and their activity in tests for the interaction of ligands with various subtypes of muscarinic receptors (M1-M4) in rats." | 7.72 | Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats. ( Beliaev, VA; Dagaev, SG; Dolgo-Saburov, VB; Filko, OA; Khrabrova, AV; Kosmachev, AB; Kubarskaya, LG; Libman, NM; Podosinovikova, NP; Sanotskii, VI, 2004) |
| " Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 7.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
| "An unusual, acute extrapyramidal reaction, which resulted from treatment with haloperidol and which was unresponsive to standard anticholinergic treatment and indistinguishable on clinical grounds from acute catatonia, is described." | 7.65 | Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol. ( Kelly, MJ; Weinberger, DR, 1977) |
| "The diagnosis of catatonia was established." | 5.36 | [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. ( Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S, 2010) |
| "Haloperidol was prescribed to control psychotic symptoms." | 5.32 | Potentiation of haloperidol neurotoxicity in acute hyperthyroidism: report of a case. ( Chu, H; Hsu, YD; Lin, JC, 2004) |
| "This article describes a patient with lethal catatonia: treatment by ECT alone was ineffective, whereas continued treatment with ECT in combination with dantrolene sodium led to improvement." | 5.28 | Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. ( Nolen, WA; Zwaan, WA, 1990) |
| "Neuroleptic-induced catatonia is reported in an adolescent patient who responded successfully to lorazepam." | 4.78 | Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. ( Woodbury, MA; Woodbury, MM, 1992) |
| " The extract at both the doses displayed a significant reduction in postural flexion, moderate decrease in tremor, muscular rigidity and postural immobility scores but do not exhibit significant lowering of hypokinesia score in reserpine induced Parkinsonian model." | 4.12 | Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates. ( Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S, 2022) |
| "Successful treatment of acute periodic catatonia was achieved with a lorazepam-diazepam protocol, and the patient remained in remission for a longer duration under clozapine treatment." | 3.85 | Periodic catatonia with long-term treatment: a case report. ( Chen, RA; Huang, TL, 2017) |
| "We studied the relationship between the efficiency of muscarinic receptor antagonists in preventing haloperidol-induced catatonia and their activity in tests for the interaction of ligands with various subtypes of muscarinic receptors (M1-M4) in rats." | 3.72 | Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats. ( Beliaev, VA; Dagaev, SG; Dolgo-Saburov, VB; Filko, OA; Khrabrova, AV; Kosmachev, AB; Kubarskaya, LG; Libman, NM; Podosinovikova, NP; Sanotskii, VI, 2004) |
| "A haloperidol-treated patient with chronic schizophrenia had a near-arrhythmic circadian rest-activity cycle, whereas rhythms of 6-sulphatoxy-melatonin and core body temperature were of normal amplitude and phase-advanced." | 3.69 | A schizophrenic patient with an arrhythmic circadian rest-activity cycle. ( Cajochen, C; Nussbaum, P; Wirz-Justice, A, 1997) |
| " Intravenous lorazepam was rapidly effective in reversing the catatonia and attendant symptoms." | 3.66 | Intravenous lorazepam in neuroleptic-induced catatonia. ( Cassem, NH; Fricchione, GL; Hobson, D; Hooberman, D, 1983) |
| "An unusual, acute extrapyramidal reaction, which resulted from treatment with haloperidol and which was unresponsive to standard anticholinergic treatment and indistinguishable on clinical grounds from acute catatonia, is described." | 3.65 | Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol. ( Kelly, MJ; Weinberger, DR, 1977) |
| "Catatonia is a rare medical condition that can be fatal in paediatric patients if left untreated." | 1.62 | Catatonia in a 10-year-old boy with early childhood neglect and disruptive behaviours in psychiatric residential treatment. ( Giggie, MA, 2021) |
| "Both delirium and catatonia have hypokinetic and hyperkinetic variants, and the two syndromes can also co-occur." | 1.62 | Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium. ( Ainsworth, A; Andrews, P; Ely, EW; Oldham, MA; Roy, K; Wilson, JE, 2021) |
| "Malignant catatonia is a life-threatening syndrome, associated mostly with psychiatric diseases but also with neurological and neurodegenerative syndromes." | 1.56 | [Malignant catatonia in dementia with Lewy Body successfully treated with sismotherapy: A case report]. ( Dhote, J; Gasnier, M; Kipman, A, 2020) |
| "A 64-year-old woman developed catatonia after experiencing persecutory delusions." | 1.37 | Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment. ( Ikeda, R; Katagiri, N; Mizumura, S; Mizuno, M; Nemoto, T; Shiraga, N; Tohgi, N; Tsujino, N; Yamaguchi, T, 2011) |
| "The diagnosis of catatonia was established." | 1.36 | [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. ( Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S, 2010) |
| "Thus, physician should consider catatonia when treating neuroleptic malignant like syndrome." | 1.36 | [Case with difficulty in differentiating between transient neuroleptic malignant syndrome and catatonia after neuroleptic analgesia]. ( Miyazaki, M; Yanagawa, Y, 2010) |
| " We treated catatonic symptoms with drugs within the upper limit of dosage and electroconvulsive therapy (ECT) to determine the maximal response." | 1.34 | Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. ( Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C, 2007) |
| "Thus it is necessary to rule out ictal catatonia by electroencephalography in patients with catatonic stupor." | 1.33 | Epileptic seizures superimposed on catatonic stupor. ( Awata, S; Ebina, Y; Honda, T; Matsuoka, H; Miura, N; Shindo, T; Suzuki, K; Takano, T, 2006) |
| "Haloperidol was prescribed to control psychotic symptoms." | 1.32 | Potentiation of haloperidol neurotoxicity in acute hyperthyroidism: report of a case. ( Chu, H; Hsu, YD; Lin, JC, 2004) |
| "Treatment and course of catatonia in an adolescent patient with Prader-Willi Syndrome are presented." | 1.30 | Catatonia in an adolescent with Prader-Willi Syndrome. ( Bouman, NH; Dhossche, DM, 1997) |
| "The relationship between NMS and catatonia and possible therapeutic decisions are discussed." | 1.29 | Neuroleptic malignant syndrome and catatonia. A report of three cases. ( Altavista, MC; Cavallari, S; Lubich, L; Raja, M, 1994) |
| "We report a case of neuroleptic malignant syndrome where the catatonia clearly followed the administration of neuroleptics and where the neurovegetative disturbance was remarkably severe, including episodes of tracheal spasm, apnoea and episodes of bradycardia, and sinus arrest requiring insertion of a temporary external pacing wire." | 1.29 | Recurrent sinus arrest in association with neuroleptic malignant syndrome. ( Hamlin, GW; Ormerod, LP; Parry, AK; Saleem, PT, 1994) |
| " After increasing the dosage of prednisone, she recovered almost completely from this episode." | 1.28 | [Cerebral disseminated lupus erythematosus; brain-racking for patient and physician]. ( de Glas-Vos, JW; Prins, JM, 1990) |
| "Neuroleptic-induced catatonia (NIC) and milder neuroleptic malignant syndrome (NMS) share parkinsonian features, catatonic symptoms, mild fever, and have been described in patients receiving antipsychotic agents." | 1.28 | Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome? ( Christodoulou, GN; Kontaxakis, VP; Vaidakis, NM; Valergaki, HC, 1990) |
| "This article describes a patient with lethal catatonia: treatment by ECT alone was ineffective, whereas continued treatment with ECT in combination with dantrolene sodium led to improvement." | 1.28 | Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. ( Nolen, WA; Zwaan, WA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (55.22) | 18.7374 |
| 1990's | 13 (19.40) | 18.2507 |
| 2000's | 5 (7.46) | 29.6817 |
| 2010's | 7 (10.45) | 24.3611 |
| 2020's | 5 (7.46) | 2.80 |
| Authors | Studies |
|---|---|
| Pal Roy, S | 1 |
| Kadiri, SK | 1 |
| Karkar, VV | 1 |
| Rao Konijeti, S | 1 |
| Gill, G | 1 |
| Segal, Y | 1 |
| Yadav, G | 1 |
| Kainth, T | 1 |
| Zachary, M | 1 |
| Riess, P | 1 |
| Dhote, J | 1 |
| Kipman, A | 1 |
| Gasnier, M | 1 |
| Giggie, MA | 1 |
| Wilson, JE | 1 |
| Andrews, P | 1 |
| Ainsworth, A | 1 |
| Roy, K | 1 |
| Ely, EW | 1 |
| Oldham, MA | 1 |
| Chen, RA | 1 |
| Huang, TL | 1 |
| Harley, JA | 1 |
| Peebles, C | 1 |
| Porter, RJ | 1 |
| Noaín, D | 1 |
| Pérez-Millán, MI | 1 |
| Bello, EP | 1 |
| Luque, GM | 1 |
| Casas Cordero, R | 1 |
| Gelman, DM | 1 |
| Peper, M | 1 |
| Tornadu, IG | 1 |
| Low, MJ | 1 |
| Becú-Villalobos, D | 1 |
| Rubinstein, M | 1 |
| Askenazy, F | 1 |
| Dor, E | 1 |
| Benoit, M | 1 |
| Dupuis, G | 1 |
| Serret, S | 1 |
| Myquel, M | 1 |
| Seddiki, Y | 1 |
| Yanagawa, Y | 1 |
| Miyazaki, M | 1 |
| Özdemir, B | 1 |
| Çelik, C | 1 |
| Çinar, A | 1 |
| Özşahin, A | 1 |
| Tsujino, N | 1 |
| Nemoto, T | 1 |
| Yamaguchi, T | 1 |
| Katagiri, N | 1 |
| Tohgi, N | 1 |
| Ikeda, R | 1 |
| Shiraga, N | 1 |
| Mizumura, S | 1 |
| Mizuno, M | 1 |
| Ghaziuddin, N | 1 |
| Alkhouri, I | 1 |
| Champine, D | 1 |
| Quinlan, P | 1 |
| Fluent, T | 1 |
| Ghaziuddin, M | 1 |
| ALEMA, G | 1 |
| GIANNIOTTI, G | 1 |
| ROSADINI, G | 1 |
| BURGERMEISTER, JJ | 1 |
| DICK, P | 1 |
| TISSOT, R | 1 |
| BOBON, J | 1 |
| COLLARD, J | 1 |
| DELREE, C | 1 |
| GERNAY, JM | 1 |
| KURLAND, AA | 1 |
| FERRO-DIAZ, P | 1 |
| MCCUSKER, K | 1 |
| BOISSIER, JR | 1 |
| SIMON, P | 1 |
| KAMENSKAIA, VM | 1 |
| ALEKSANDROVSKII, IuA | 1 |
| Dagaev, SG | 1 |
| Kosmachev, AB | 1 |
| Filko, OA | 1 |
| Kubarskaya, LG | 1 |
| Khrabrova, AV | 1 |
| Beliaev, VA | 1 |
| Podosinovikova, NP | 1 |
| Libman, NM | 1 |
| Sanotskii, VI | 1 |
| Dolgo-Saburov, VB | 1 |
| Chu, H | 1 |
| Lin, JC | 1 |
| Hsu, YD | 1 |
| Suzuki, K | 1 |
| Miura, N | 1 |
| Awata, S | 1 |
| Ebina, Y | 1 |
| Takano, T | 1 |
| Honda, T | 1 |
| Shindo, T | 1 |
| Matsuoka, H | 1 |
| Hatta, K | 1 |
| Miyakawa, K | 1 |
| Ota, T | 1 |
| Usui, C | 1 |
| Nakamura, H | 1 |
| Arai, H | 1 |
| Fricchione, GL | 1 |
| Cassem, NH | 1 |
| Hooberman, D | 1 |
| Hobson, D | 1 |
| Stoudemire, A | 1 |
| Luther, JS | 1 |
| Mashiah, T | 1 |
| Mashiah, A | 1 |
| Gomez, EA | 1 |
| Comstock, BS | 1 |
| Rosario, A | 1 |
| Cremona-Barbaro, A | 1 |
| Dosani, RA | 1 |
| Gaertner, HJ | 1 |
| Hörner, W | 1 |
| Bartels, M | 1 |
| de Sousa Moreira, LF | 1 |
| Pinheiro, MC | 1 |
| Masur, J | 1 |
| Nakra, BR | 1 |
| Hwu, HG | 1 |
| Myslobodsky, MS | 1 |
| Mintz, M | 1 |
| Raja, M | 1 |
| Altavista, MC | 1 |
| Cavallari, S | 1 |
| Lubich, L | 1 |
| Parry, AK | 1 |
| Ormerod, LP | 1 |
| Hamlin, GW | 1 |
| Saleem, PT | 1 |
| Franz, M | 1 |
| Gallhofer, B | 1 |
| Kanzow, WT | 1 |
| Greedharry, D | 1 |
| Bowen, R | 1 |
| Marneros, A | 1 |
| Jäger, A | 1 |
| Northoff, G | 1 |
| Wenke, J | 1 |
| Pflug, B | 1 |
| Wirz-Justice, A | 1 |
| Cajochen, C | 1 |
| Nussbaum, P | 1 |
| Dhossche, DM | 1 |
| Bouman, NH | 1 |
| Brenner, I | 1 |
| Rheuban, WJ | 1 |
| Gelenberg, AJ | 1 |
| Mandel, MR | 1 |
| Weinberger, DR | 1 |
| Kelly, MJ | 1 |
| Casacchia, M | 2 |
| Carchedi, F | 2 |
| Cerbo, R | 2 |
| Meco, G | 1 |
| Agnoli, A | 1 |
| Woodbury, MM | 1 |
| Woodbury, MA | 1 |
| Chandler, JD | 1 |
| Prins, JM | 1 |
| de Glas-Vos, JW | 1 |
| Kontaxakis, VP | 1 |
| Vaidakis, NM | 1 |
| Christodoulou, GN | 1 |
| Valergaki, HC | 1 |
| Nolen, WA | 1 |
| Zwaan, WA | 1 |
| Bowers, MB | 1 |
| Aley, KO | 1 |
| Kulkarni, SK | 1 |
| Herrmann, N | 1 |
| Lieff, SJ | 1 |
| Rampertaap, MP | 1 |
| Hoffman, AS | 1 |
| Schwartz, HI | 1 |
| Novick, RM | 1 |
| Fischer, W | 1 |
| Rabending, G | 1 |
| Valenstein, M | 1 |
| Maltbie, A | 1 |
| Kaplan, P | 1 |
| Pollet, P | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Gjessing, LR | 1 |
| Mori, J | 1 |
| Sato, Y | 1 |
| Oashi, T | 1 |
| Hitomi, M | 1 |
| Wauquier, A | 1 |
| Niemegeers, CJ | 1 |
| Lal, H | 1 |
| Cocito, E | 1 |
| Ambrosini, G | 1 |
| Arata, A | 1 |
| Bevilacqua, P | 1 |
| Tortora, E | 1 |
| Zolotnitskii, RI | 1 |
| Kutsenok, BM | 1 |
| Gastev, MD | 1 |
| Smulevich, AB | 1 |
| Golovan', LI | 1 |
| Sokolova, ED | 1 |
| Tsutsul'kovskaia, MIa | 1 |
| Greger, J | 1 |
| Glitschka, A | 1 |
| Müller, K | 1 |
3 reviews available for haloperidol and Catatonia
| Article | Year |
|---|---|
Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
Topics: Adolescent; Catatonia; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Neuroleptic | 1992 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differ | 1986 |
[Contribution to the study of experimental catatonia in guinea pigs. Effect of various psychoactive drugs on this phenomenon].
Topics: Animals; Catatonia; Chlorpromazine; Female; Guinea Pigs; Haloperidol; Male; Meprobamate; Perphenazin | 1967 |
1 trial available for haloperidol and Catatonia
| Article | Year |
|---|---|
Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
Topics: Adult; Asthenia; Benperidol; Catatonia; Clinical Trials as Topic; Depression; Haloperidol; Humans; H | 1970 |
63 other studies available for haloperidol and Catatonia
| Article | Year |
|---|---|
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antipar | 2022 |
Catatonia and Competency to Stand Trial With Unique Response to Haloperidol.
Topics: Adult; Catatonia; Haloperidol; Humans; Male | 2023 |
[Malignant catatonia in dementia with Lewy Body successfully treated with sismotherapy: A case report].
Topics: Aged; Antipsychotic Agents; Catatonia; Critical Care; Delusions; Depressive Disorder, Major; Electro | 2020 |
Catatonia in a 10-year-old boy with early childhood neglect and disruptive behaviours in psychiatric residential treatment.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Child; Child, Preschool; Haloperidol; Humans; Male; Pro | 2021 |
Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium.
Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Catatonia; Delirium; Diagnosis, Differential; | 2021 |
Periodic catatonia with long-term treatment: a case report.
Topics: Antipsychotic Agents; Catatonia; Clozapine; Drug Therapy, Combination; Female; Haloperidol; Humans; | 2017 |
Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.
Topics: Adult; Antipsychotic Agents; Catatonia; Electroconvulsive Therapy; Female; Hallucinations; Haloperid | 2019 |
Central dopamine D2 receptors regulate growth-hormone-dependent body growth and pheromone signaling to conspecific males.
Topics: Analysis of Variance; Animals; Benzamides; Body Size; Body Weight; Case-Control Studies; Catatonia; | 2013 |
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Cataplexy; C | 2010 |
[Case with difficulty in differentiating between transient neuroleptic malignant syndrome and catatonia after neuroleptic analgesia].
Topics: Adolescent; Analgesia; Anesthesia, General; Catatonia; Diagnosis, Differential; Diazepam; Droperidol | 2010 |
Relief by electroconvulsive therapy for postsurgical delirium in malignant catatonia.
Topics: Antipsychotic Agents; Cardiac Surgical Procedures; Catatonia; Coronary Artery Bypass; Delirium; Elec | 2010 |
Cerebral blood flow changes in very-late-onset schizophrenia-like psychosis with catatonia before and after successful treatment.
Topics: Antipsychotic Agents; Aripiprazole; Brain; Brain Mapping; Catatonia; Cerebrovascular Circulation; Fe | 2011 |
ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment.
Topics: Adolescent; Benzodiazepines; Brain; Catatonia; Diagnosis, Differential; Diagnostic Imaging; Electroc | 2002 |
[Experimental catatonia induced by neuroleptic drugs. II. Action of Haloperidol].
Topics: Antipsychotic Agents; Catatonia; Haloperidol; Humans; Hypnotics and Sedatives | 1961 |
[Effect of certain cataleptic drugs on the ocular motility of patients with hebephreno-catatonia].
Topics: Catatonia; Eye Movements; Haloperidol; Humans; Tranquilizing Agents | 1963 |
[SPIROPERIDOL].
Topics: Catatonia; Geriatrics; Hallucinations; Haloperidol; Humans; Hypnotics and Sedatives; Paranoid Disord | 1963 |
THE BUTYROPHENONES IN THE TREATMENT OF THE PSYCHOTIC PATIENT.
Topics: Biomedical Research; Butyrophenones; Catatonia; Haloperidol; Humans; Meperidine; Paranoid Disorders; | 1964 |
[EXPERIMENTAL EQUIVALENTS OF THE NEUROLOGIC SYNDROME OF NEUROLEPTICS].
Topics: Antipsychotic Agents; Catalepsy; Catatonia; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Neuro | 1964 |
[CLINICO-ELECTROENCEPHALOGRAPHIC STUDY OF THE EFFECT OF HALOPERIDOL ON SCHIZOPHRENICS].
Topics: Catatonia; Depression; Depressive Disorder; Drug Therapy; Electroencephalography; Haloperidol; Human | 1964 |
Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats.
Topics: Animals; Basal Ganglia Diseases; Catatonia; Haloperidol; Kinetics; Ligands; Male; Models, Biological | 2004 |
Potentiation of haloperidol neurotoxicity in acute hyperthyroidism: report of a case.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Catatonia; Haloperidol; Humans; Hyperthyroidism | 2004 |
Epileptic seizures superimposed on catatonic stupor.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Catatonia; Combined Modality Therapy; | 2006 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relation | 2007 |
Intravenous lorazepam in neuroleptic-induced catatonia.
Topics: Adult; Aged; Antipsychotic Agents; Catatonia; Female; Haloperidol; Humans; Injections, Intravenous; | 1983 |
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; F | 1984 |
Catatonic-like syndrome.
Topics: Aged; Catatonia; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Indomethacin; Parano | 1983 |
Organic versus functional etiology in catatonia: case report.
Topics: Adult; Catatonia; Diagnosis, Differential; Epilepsy, Post-Traumatic; Haloperidol; Humans; Male; Neur | 1982 |
Neuroleptic-induced catatonic symptoms.
Topics: Adolescent; Catatonia; Female; Haloperidol; Humans | 1983 |
Haloperidol-induced neuroleptic malignant syndrome.
Topics: Adult; Catatonia; Fever; Haloperidol; Humans; Male; Psychoses, Substance-Induced; Schizophrenia; Syn | 1983 |
[Catatonic symptoms as a side effect of neuroleptic treatment].
Topics: Adult; Catatonia; Diagnosis, Differential; Drug Therapy, Combination; Female; Haloperidol; Humans; M | 1983 |
Catatonic behavior induced by haloperidol, increased by retesting and elicited without drug in rats.
Topics: Animals; Behavior, Animal; Catatonia; Haloperidol; Humans; Male; Rats; Rats, Inbred Strains | 1982 |
Catatonic-like syndrome during neuroleptic therapy.
Topics: Aged; Catatonia; Female; Fluphenazine; Haloperidol; Humans | 1982 |
Postictal behavioral arrest in the rat: "catalepsy" or "catatonia"?
Topics: Animals; Apomorphine; Behavior, Animal; Catalepsy; Catatonia; Electric Stimulation; Female; Haloperi | 1981 |
Neuroleptic malignant syndrome and catatonia. A report of three cases.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive Disorder; Dibenzothiazepines; D | 1994 |
Recurrent sinus arrest in association with neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Cardiac Pacing, Artificial; Catatonia; Chlorpromazine; Clopenthixol; Dr | 1994 |
Treatment of catatonia with intravenous biperidene.
Topics: Adult; Biperiden; Catatonia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Th | 1994 |
Lethal catatonia and neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Diagnosis, Differential; Dose-Response Rel | 1993 |
Treatment of catatonic stupor with oral lorazepam in 14-year-old psychotic boy.
Topics: Adolescent; Catatonia; Haloperidol; Humans; Lorazepam; Male; Psychotic Disorders | 1993 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; D | 1996 |
A schizophrenic patient with an arrhythmic circadian rest-activity cycle.
Topics: Adult; Antipsychotic Agents; Bed Rest; Body Temperature; Catatonia; Chronic Disease; Circadian Rhyth | 1997 |
Catatonia in an adolescent with Prader-Willi Syndrome.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Haloperidol; Humans; Lorazepam; Male; Neurologic Examin | 1997 |
The catatonic dilemma.
Topics: Adult; Catatonia; Haloperidol; Humans; Male; Schizophrenia, Catatonic; Schizophrenic Psychology | 1978 |
Catatonic reactions to high-potency neuroleptic drugs.
Topics: Adolescent; Adult; Amantadine; Catatonia; Dose-Response Relationship, Drug; Female; Fluphenazine; Ha | 1977 |
Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol.
Topics: Adult; Basal Ganglia Diseases; Benztropine; Catatonia; Diagnosis, Differential; Haloperidol; Humans; | 1977 |
[Role of serotonin in stereotyped movements induced with amphetamine in rats with haloperidol-induced catatonia].
Topics: Amphetamine; Animals; Catatonia; Haloperidol; Humans; Rats; Serotonin | 1976 |
[Role of serotonin in catatonia induced with haloperidol and reserpine].
Topics: Animals; Brain; Catatonia; Haloperidol; Humans; Male; Rats; Reserpine; Serotonin; Serotonin Antagoni | 1976 |
Psychogenic catatonia with elevated creatine kinase and autonomic hyperactivity.
Topics: Adult; Arousal; Autonomic Nervous System; Catatonia; Combined Modality Therapy; Creatine Kinase; Del | 1991 |
[Cerebral disseminated lupus erythematosus; brain-racking for patient and physician].
Topics: Adult; Catatonia; Drug Therapy, Combination; Female; Haloperidol; Humans; Lupus Erythematosus, Syste | 1990 |
Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
Topics: Adult; Catatonia; Diagnosis, Differential; Haloperidol; Humans; Injections, Intramuscular; Male; Neu | 1990 |
Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report.
Topics: Adolescent; Catatonia; Combined Modality Therapy; Dantrolene; Diazepam; Electroconvulsive Therapy; H | 1990 |
Cerebrospinal fluid homovanillic acid and hypokinetic side effects of neuroleptics.
Topics: Acetylcholine; Adolescent; Adult; Antipsychotic Agents; Catatonia; Chlorpromazine; Dopamine; Female; | 1985 |
Anticatatonic effect of venoruton.
Topics: Animals; Anticoagulants; Antipsychotic Agents; Catatonia; Female; Haloperidol; Hydroxyethylrutoside; | 1988 |
Drug-induced catatonia.
Topics: Aged; Aged, 80 and over; Catatonia; Dementia; Depressive Disorder; Drug Therapy, Combination; Female | 1988 |
Catatonic reaction to accidental haloperidol overdose: an unrecognized drug abuse risk.
Topics: Adult; Catatonia; Haloperidol; Humans; Male; Parkinson Disease, Secondary; Substance-Related Disorde | 1986 |
[Psychomotor status with catatonic stupor following high dosage neuroleptic therapy].
Topics: Adult; Catatonia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalograph | 1986 |
Catatonia in the emergency department.
Topics: Adult; Aged; Bipolar Disorder; Catatonia; Diagnosis, Differential; Emergency Service, Hospital; Halo | 1985 |
On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity.
Topics: Amygdala; Animals; Atropine; Catalepsy; Catatonia; Caudate Nucleus; Corpus Striatum; Dose-Response R | 1974 |
A review of periodic catatonia.
Topics: Age Factors; Animals; Arousal; Basal Metabolism; Body Temperature; Body Weight; Catatonia; Chlorprom | 1974 |
[Pharmacological study of amantadine, a new antiparkinson drug].
Topics: Amantadine; Amines; Animals; Antiparkinson Agents; Avoidance Learning; Brain; Catatonia; Dopamine; D | 1974 |
Differential antagonism by naloxone of inhibitory effects of haloperidol and morphine on brain self-stimulation.
Topics: Animals; Behavior, Animal; Blepharoptosis; Brain; Catalepsy; Catatonia; Electric Stimulation; Electr | 1974 |
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall | 1969 |
[On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
Topics: Catatonia; Chlordiazepoxide; Chlorpromazine; Haloperidol; Humans; Paranoid Disorders; Perphenazine; | 1968 |
[On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Topics: Adult; Aged; Bipolar Disorder; Catatonia; Child; Depression; Depressive Disorder, Major; Extrapyrami | 1968 |